S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
OTCMKTS:CSLLY

CSL (CSLLY) Stock Price, News & Analysis

$94.29
+0.41 (+0.44%)
(As of 03/28/2024 ET)
Today's Range
$91.79
$95.83
50-Day Range
$89.91
$99.41
52-Week Range
$71.51
$105.11
Volume
22,690 shs
Average Volume
30,603 shs
Market Capitalization
$91.13 billion
P/E Ratio
N/A
Dividend Yield
1.16%
Price Target
N/A

CSL MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.57mentions of CSL in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.97%
From $3.15 to $3.59 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.59 out of 5 stars

CSLLY stock logo

About CSL Stock (OTCMKTS:CSLLY)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

CSLLY Stock Price History

CSLLY Stock News Headlines

Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
CSL Ltd's Dividend Analysis
Wilsons downgrades CSL (CMXHF) to a Hold
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
CSL share price on watch amid 20% profit jump
CSL Says 1H Profit Rises, Boosts Dividend -- Update
CSL Profit Rises, Boosts Dividend
Are CSL shares set for an earnings boost?
All hands on deck for employee growth at CSL
CSL worker held for 'spying' on Navy ship
QURE Jan 2024 25.000 call
QURE Jan 2024 5.000 call
See More Headlines
Receive CSLLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/29/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:CSLLY
Employees
32,000
Year Founded
1904

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$13.31 billion
Cash Flow
$3.20 per share
Book Value
$18.48 per share

Miscellaneous

Free Float
N/A
Market Cap
$91.13 billion
Optionable
Not Optionable
Beta
0.73
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Dr. Paul F. McKenzie Ph.D. (Age 58)
    MD, CEO & Executive Director
    Comp: $2.75M
  • Ms. Joy Carolyn Linton B.Com. (Age 59)
    BComm, GAICD, Grad Dip AFI, Chief Financial Officer
    Comp: $2.05M
  • Mr. Mark Dehring
    Head of Investor Relations
  • Mr. Gregory Boss B.S. (Age 63)
    BS(Hons), J.D., Executive VP of Legal & General Counsel
    Comp: $1.1M
  • Christina Hickie
    Senior Manager of Communications
  • Ms. Roanne Parry
    Chief Human Resources Officer
  • Dr. Karen Etchberger (Age 66)
    Executive Vice President of Quality & Business Services
    Comp: $1.03M
  • Ms. Jemimah Brennan
    Head of Communications - Asia Pacific
  • Dr. Andrew D. Nash BSc (Hons) (Age 62)
    GAICD, Ph.D., Senior Vice President of Research
  • Dr. William Mezzanotte M.D. (Age 65)
    M.P.H., Executive VP & Head of Research and Development
    Comp: $1.46M

Should I Buy CSL Stock? CSLLY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in CSL Limited:

  • CSL Limited operates in the biopharmaceutical and vaccines industry, which has shown resilience and growth potential, especially during global health crises.
  • The company has a diverse product portfolio, including plasma products, gene therapies, and recombinants, catering to various therapeutic areas.
  • Recent developments indicate that CSL Limited has been investing in research and development, potentially leading to innovative products and market expansion.
  • CSL Limited's stock price has shown stability and a positive trend, reflecting investor confidence in the company's performance.
  • CSL Limited has a strong international presence, with operations in multiple countries, providing geographical diversification and market stability.

Cons

Investors should be bearish about investing in CSL Limited for these reasons:

  • CSL Limited's outstanding shares and institutional ownership percentage are currently not available, potentially indicating limited transparency or investor interest.
  • The short percentage of float for CSL Limited is currently at 0, which may suggest lower market interest or trading activity compared to other stocks.
  • CSL Limited's float size is listed as 0, which could raise concerns about liquidity and market depth for potential investors.
  • The month-to-month change percentage in shares shorted for CSL Limited is negative, indicating a possible decrease in market sentiment towards the stock.
  • CSL Limited's Days to Cover ratio is very low at 0.3, which may imply a higher risk of short squeezes or volatility in the stock price.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, March 27, 2024. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com.

CSLLY Stock Analysis - Frequently Asked Questions

How have CSLLY shares performed in 2024?

CSL's stock was trading at $97.17 on January 1st, 2024. Since then, CSLLY shares have decreased by 3.0% and is now trading at $94.29.
View the best growth stocks for 2024 here
.

Are investors shorting CSL?

CSL saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 5,200 shares, a drop of 40.2% from the February 29th total of 8,700 shares. Based on an average trading volume of 64,300 shares, the short-interest ratio is presently 0.1 days.
View CSL's Short Interest
.

Is CSL a good dividend stock?

CSL (OTCMKTS:CSLLY) pays an annual dividend of $1.09 per share and currently has a dividend yield of 1.18%.
Read our dividend analysis for CSLLY.

How do I buy shares of CSL?

Shares of CSLLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CSLLY) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners